Béga Murray, PhD
Postdoctoral Associate
bega.murray@rutgers.edu
Béga completed her PhD through a graduate partnership program between Queen’s University Belfast in Northern Ireland and the National Cancer Institute (NCI) at the National Institutes of Health, USA. Her PhD and early postdoctoral training at the NCI focused on the epigenetic regulation of malignant peripheral nerve sheath tumors (MPNST). In the Zhang lab, Béga’s research focuses on transcriptional regulatory processes and oncogenic activation involved in the malignant transformation of benign plexiform neurofibromas to MPNST.
Sarah Morrow, PhD
Postdoctoral Associate
skm232@cinj.rutgers.edu
Sarah completed her PhD in Pharmacology with a minor in Translational Cancer Biology at Indiana University School of Medicine in 2026, where she was supported by a Young Investigator Award from the Children’s Tumor Foundation. In the Zhang lab, Sarah studies the molecular changes that drive the progression of benign nerve sheath tumors toward MPNST, with a focus on identifying key regulators of malignant transformation. Outside the lab, Sarah enjoys Irish dancing, cooking, socializing with friends, and karaoke.
Wenyi Wang, MS
Research Teaching Specialist IV
ww511@cinj.rutgers.edu
Wenyi earned her M.S. in Molecular Pharmacology and Therapeutics (MPaT) from the University of Minnesota Twin Cities in 2025. In the Zhang lab, she is exploring the mechanisms underlying the malignant transformation of NF1-associated nerve sheath tumors. Outside the lab, Wenyi enjoys visiting museums, watching documentaries, and playing badminton.